Onconetix Sets 1-for-5 Reverse Stock Split, Stock Down

Onconetix announced a 1-for-5 reverse stock split effective 12:01 a.m. ET on March 25, 2026. Shares fell about 12% on the news as the stock will begin trading on a split-adjusted basis, signaling near-term negative investor sentiment and potential continued volatility in the equity.

Analysis

Onconetix announced a 1-for-5 reverse stock split effective 12:01 a.m. ET on March 25, 2026. Shares fell about 12% on the news as the stock will begin trading on a split-adjusted basis, signaling near-term negative investor sentiment and potential continued volatility in the equity.